Schellekens AFA - Search Results

1

Often Overlooked and Ignored, but Do Not Underestimate Its Relevance: ADHD in Addiction - Addiction in ADHD.

Schellekens AFA, van den Brink W, Kiefer F, Goudriaan AE. Schellekens AFA, et al. Eur Addict Res. 2020;26(4-5):169-172. doi: 10.1159/000509267. Epub 2020 Jul 2. Eur Addict Res. 2020. PMID: 32615559 Free PMC article. No abstract available.

2

Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder.

Groenman AP, Greven CU, van Donkelaar MM, Schellekens A, van Hulzen KJ, Rommelse N, Hartman CA, Hoekstra PJ, Luman M, Franke B, Faraone SV, Oosterlaan J, Buitelaar JK. Groenman AP, et al. Addict Biol. 2016 Jul;21(4):915-23. doi: 10.1111/adb.12230. Epub 2015 Mar 6. Addict Biol. 2016. PMID: 25752199 Free PMC article.

3

Addiction training for health professionals as an antidote to the addiction health burden in Indonesia.

Ayu AP, Iskandar S, Siste K, De Jong C, Schellekens A. Ayu AP, et al. Addiction. 2016 Aug;111(8):1498-9. doi: 10.1111/add.13407. Epub 2016 May 5. Addiction. 2016. PMID: 27154740 No abstract available.

4

A Brief Outline of the Use of New Technologies for Treating Substance Use Disorders in the European Union.

Quaglio G, Schellekens A, Blankers M, Hoch E, Karapiperis T, Esposito G, Brand H, Nutt D, Kiefer F. Quaglio G, et al. Eur Addict Res. 2017;23(4):177-181. doi: 10.1159/000478904. Epub 2017 Aug 12. Eur Addict Res. 2017. PMID: 28803249

5

International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.

Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A; ICASA consensus group; Matthys F. Crunelle CL, et al. Eur Addict Res. 2018;24(1):43-51. doi: 10.1159/000487767. Epub 2018 Mar 6. Eur Addict Res. 2018. PMID: 29510390 Free PMC article.

6

Relating addiction and psychiatric disorders.

Vink JM, Schellekens A. Vink JM, et al. Science. 2018 Sep 28;361(6409):1323-1324. doi: 10.1126/science.aav3928. Science. 2018. PMID: 30262491 No abstract available.

7

Cost-Effectiveness Analysis of Genotype-Guided Treatment Allocation in Patients with Alcohol Use Disorders Using Naltrexone or Acamprosate, Using a Modeling Approach.

Sluiter RL, Kievit W, van der Wilt GJ, Schene AH, Teichert M, Coenen MJH, Schellekens A. Sluiter RL, et al. Eur Addict Res. 2018;24(5):245-254. doi: 10.1159/000494127. Epub 2018 Nov 1. Eur Addict Res. 2018. PMID: 30384381 Free PMC article.

8

Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study.

Kalkman GA, Kramers C, van Dongen RT, van den Brink W, Schellekens A. Kalkman GA, et al. Lancet Public Health. 2019 Oct;4(10):e498-e505. doi: 10.1016/S2468-2667(19)30128-8. Epub 2019 Aug 20. Lancet Public Health. 2019. PMID: 31444001 Free article.

9

Tackling rising numbers of opioid prescriptions users.

Kalkman GA, Kramers C, van Dongen RT, van den Brink W, Schellekens A. Kalkman GA, et al. Lancet Public Health. 2020 Mar;5(3):e139. doi: 10.1016/S2468-2667(20)30029-3. Lancet Public Health. 2020. PMID: 32113517 Free article. No abstract available.

10

Effects of Recreational GHB Use and Multiple GHB-Induced Comas on Brain Structure and Impulsivity.

Raposo Pereira F, McMaster MTB, Schellekens A, Polderman N, de Vries YDAT, van den Brink W, van Wingen GA. Raposo Pereira F, et al. Front Psychiatry. 2020 Apr 2;11:166. doi: 10.3389/fpsyt.2020.00166. eCollection 2020. Front Psychiatry. 2020. PMID: 32300311 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page